Efficacy of tucatinib plus trastuzumab plus capecitabine (TTC) after trastuzumab-deruxtecan (TDXd) exposure in Her2-positive metastatic breast cancer: A French multicentre retrospective study

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要